Figure 1
From: Angiopoietin-1 variant reduces LPS-induced microvascular dysfunction in a murine model of sepsis
MAT.Ang-1 reduces lipopolysaccharide-induced microvascular leak. (A) Representative images at 24 hours of murine skeletal muscle microvasculature from control (CTR), lipopolysaccharide (LPS)-treated, LPS + matrilin-1-angiopoietin-1 (MAT-Ang1)-treated and MAT-Ang1-treated groups. (B) Data expressed as mean ± standard error of the mean for change in grey level indicating macromolecular leak from 20 hours (n = 6). **P < 0.01 and ***P < 0.001 vs. control. #P < 0.05 and ###P < 0.001 vs. LPS.